Michael Epstein

Michael Epstein is an accomplished professional in the fields of translational research and bioinformatics, currently serving as the Vice President and Head of Translational Research at Evotec since September 2022. Prior to this role, Michael held various positions at Illumina and Achilles Therapeutics UK Limited, where responsibilities included Director of Translational Science and Senior Bioinformatics Software Developer. Michael's academic background includes multiple degrees in systems biology, bioinformatics, computer science, and economics from prestigious institutions such as UCL and Imperial College London.